ESTABLISHMENT OF A HUMAN EMBRYONIC STEM CELL LINE USING MAMMALIAN CELLS

Purified preparations of human embryonic stem cells with certain population- specific characteristics are disclosed. This preparation is characterized by the positive expression of the following pluripotent cell surface markers: SSEA-1 (-); SSEA-4 (+); TRA-1-60 (+); TRA-1-81 (+); alkaline phosphatas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BIPASHA, BOSE, TIPNIS, SHABARI, ALAM, KHAN FIRDOS, JAYANT, KULKAMI, RAJARSHI, PAL, GEETA, RAVINDRAN, ARUNDHATI, MANDAL, ARNEET, PATKI, APARNA, KHANNA
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BIPASHA, BOSE
TIPNIS, SHABARI
ALAM, KHAN FIRDOS
JAYANT, KULKAMI
RAJARSHI, PAL
GEETA, RAVINDRAN
ARUNDHATI, MANDAL
ARNEET, PATKI
APARNA, KHANNA
description Purified preparations of human embryonic stem cells with certain population- specific characteristics are disclosed. This preparation is characterized by the positive expression of the following pluripotent cell surface markers: SSEA-1 (-); SSEA-4 (+); TRA-1-60 (+); TRA-1-81 (+); alkaline phosphatase (+) , as well as a set of ES cell markers including Oct-4, Nanog, Rexl, Sox2, Thyl , FGF4, ABCG2, Dppa5, UTFl, Criptol, hTERT, Connexin-43 and Connexin-45. The cells of the preparation are negative for lineage specific markers like Keratin 8, Sox-1, NFH (ectoderm), MyoD, brachyury, cardiac-actin (mesoderm), HNF-3 beta, albumin, and PDXl (endoderm). The cells of the preparation are human embryonic stem cells, have normal karyotypes, exhibit high telomerase activity and continue to proliferate in an undifferentiated state after continuous culture for over 40 passages. The embryonic stem cell line RelicellTM Hes1 also retains the ability, throughout the culture, to differentiate into cell and tissue types derived from all three embryonic ge rm layers (endoderm, mesoderm and ectoderm). Methods for isolating a human embryonic stem cell line are also disclosed.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2608833A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2608833A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2608833A13</originalsourceid><addsrcrecordid>eNrjZHB3DQ5xdPLxDPbwdfULUfB3U3BU8Aj1dfRTcPV1Cor09_N0VggOcfVVcHb18VHw8fRzVQgN9vRzV_B19PV19PEEKgTJBPMwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUknhnRyMzAwsLY2NHQ2MilAAAXeQrwQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ESTABLISHMENT OF A HUMAN EMBRYONIC STEM CELL LINE USING MAMMALIAN CELLS</title><source>esp@cenet</source><creator>BIPASHA, BOSE ; TIPNIS, SHABARI ; ALAM, KHAN FIRDOS ; JAYANT, KULKAMI ; RAJARSHI, PAL ; GEETA, RAVINDRAN ; ARUNDHATI, MANDAL ; ARNEET, PATKI ; APARNA, KHANNA</creator><creatorcontrib>BIPASHA, BOSE ; TIPNIS, SHABARI ; ALAM, KHAN FIRDOS ; JAYANT, KULKAMI ; RAJARSHI, PAL ; GEETA, RAVINDRAN ; ARUNDHATI, MANDAL ; ARNEET, PATKI ; APARNA, KHANNA</creatorcontrib><description>Purified preparations of human embryonic stem cells with certain population- specific characteristics are disclosed. This preparation is characterized by the positive expression of the following pluripotent cell surface markers: SSEA-1 (-); SSEA-4 (+); TRA-1-60 (+); TRA-1-81 (+); alkaline phosphatase (+) , as well as a set of ES cell markers including Oct-4, Nanog, Rexl, Sox2, Thyl , FGF4, ABCG2, Dppa5, UTFl, Criptol, hTERT, Connexin-43 and Connexin-45. The cells of the preparation are negative for lineage specific markers like Keratin 8, Sox-1, NFH (ectoderm), MyoD, brachyury, cardiac-actin (mesoderm), HNF-3 beta, albumin, and PDXl (endoderm). The cells of the preparation are human embryonic stem cells, have normal karyotypes, exhibit high telomerase activity and continue to proliferate in an undifferentiated state after continuous culture for over 40 passages. The embryonic stem cell line RelicellTM Hes1 also retains the ability, throughout the culture, to differentiate into cell and tissue types derived from all three embryonic ge rm layers (endoderm, mesoderm and ectoderm). Methods for isolating a human embryonic stem cell line are also disclosed.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20070222&amp;DB=EPODOC&amp;CC=CA&amp;NR=2608833A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20070222&amp;DB=EPODOC&amp;CC=CA&amp;NR=2608833A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BIPASHA, BOSE</creatorcontrib><creatorcontrib>TIPNIS, SHABARI</creatorcontrib><creatorcontrib>ALAM, KHAN FIRDOS</creatorcontrib><creatorcontrib>JAYANT, KULKAMI</creatorcontrib><creatorcontrib>RAJARSHI, PAL</creatorcontrib><creatorcontrib>GEETA, RAVINDRAN</creatorcontrib><creatorcontrib>ARUNDHATI, MANDAL</creatorcontrib><creatorcontrib>ARNEET, PATKI</creatorcontrib><creatorcontrib>APARNA, KHANNA</creatorcontrib><title>ESTABLISHMENT OF A HUMAN EMBRYONIC STEM CELL LINE USING MAMMALIAN CELLS</title><description>Purified preparations of human embryonic stem cells with certain population- specific characteristics are disclosed. This preparation is characterized by the positive expression of the following pluripotent cell surface markers: SSEA-1 (-); SSEA-4 (+); TRA-1-60 (+); TRA-1-81 (+); alkaline phosphatase (+) , as well as a set of ES cell markers including Oct-4, Nanog, Rexl, Sox2, Thyl , FGF4, ABCG2, Dppa5, UTFl, Criptol, hTERT, Connexin-43 and Connexin-45. The cells of the preparation are negative for lineage specific markers like Keratin 8, Sox-1, NFH (ectoderm), MyoD, brachyury, cardiac-actin (mesoderm), HNF-3 beta, albumin, and PDXl (endoderm). The cells of the preparation are human embryonic stem cells, have normal karyotypes, exhibit high telomerase activity and continue to proliferate in an undifferentiated state after continuous culture for over 40 passages. The embryonic stem cell line RelicellTM Hes1 also retains the ability, throughout the culture, to differentiate into cell and tissue types derived from all three embryonic ge rm layers (endoderm, mesoderm and ectoderm). Methods for isolating a human embryonic stem cell line are also disclosed.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHB3DQ5xdPLxDPbwdfULUfB3U3BU8Aj1dfRTcPV1Cor09_N0VggOcfVVcHb18VHw8fRzVQgN9vRzV_B19PV19PEEKgTJBPMwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUknhnRyMzAwsLY2NHQ2MilAAAXeQrwQ</recordid><startdate>20070222</startdate><enddate>20070222</enddate><creator>BIPASHA, BOSE</creator><creator>TIPNIS, SHABARI</creator><creator>ALAM, KHAN FIRDOS</creator><creator>JAYANT, KULKAMI</creator><creator>RAJARSHI, PAL</creator><creator>GEETA, RAVINDRAN</creator><creator>ARUNDHATI, MANDAL</creator><creator>ARNEET, PATKI</creator><creator>APARNA, KHANNA</creator><scope>EVB</scope></search><sort><creationdate>20070222</creationdate><title>ESTABLISHMENT OF A HUMAN EMBRYONIC STEM CELL LINE USING MAMMALIAN CELLS</title><author>BIPASHA, BOSE ; TIPNIS, SHABARI ; ALAM, KHAN FIRDOS ; JAYANT, KULKAMI ; RAJARSHI, PAL ; GEETA, RAVINDRAN ; ARUNDHATI, MANDAL ; ARNEET, PATKI ; APARNA, KHANNA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2608833A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2007</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>BIPASHA, BOSE</creatorcontrib><creatorcontrib>TIPNIS, SHABARI</creatorcontrib><creatorcontrib>ALAM, KHAN FIRDOS</creatorcontrib><creatorcontrib>JAYANT, KULKAMI</creatorcontrib><creatorcontrib>RAJARSHI, PAL</creatorcontrib><creatorcontrib>GEETA, RAVINDRAN</creatorcontrib><creatorcontrib>ARUNDHATI, MANDAL</creatorcontrib><creatorcontrib>ARNEET, PATKI</creatorcontrib><creatorcontrib>APARNA, KHANNA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BIPASHA, BOSE</au><au>TIPNIS, SHABARI</au><au>ALAM, KHAN FIRDOS</au><au>JAYANT, KULKAMI</au><au>RAJARSHI, PAL</au><au>GEETA, RAVINDRAN</au><au>ARUNDHATI, MANDAL</au><au>ARNEET, PATKI</au><au>APARNA, KHANNA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ESTABLISHMENT OF A HUMAN EMBRYONIC STEM CELL LINE USING MAMMALIAN CELLS</title><date>2007-02-22</date><risdate>2007</risdate><abstract>Purified preparations of human embryonic stem cells with certain population- specific characteristics are disclosed. This preparation is characterized by the positive expression of the following pluripotent cell surface markers: SSEA-1 (-); SSEA-4 (+); TRA-1-60 (+); TRA-1-81 (+); alkaline phosphatase (+) , as well as a set of ES cell markers including Oct-4, Nanog, Rexl, Sox2, Thyl , FGF4, ABCG2, Dppa5, UTFl, Criptol, hTERT, Connexin-43 and Connexin-45. The cells of the preparation are negative for lineage specific markers like Keratin 8, Sox-1, NFH (ectoderm), MyoD, brachyury, cardiac-actin (mesoderm), HNF-3 beta, albumin, and PDXl (endoderm). The cells of the preparation are human embryonic stem cells, have normal karyotypes, exhibit high telomerase activity and continue to proliferate in an undifferentiated state after continuous culture for over 40 passages. The embryonic stem cell line RelicellTM Hes1 also retains the ability, throughout the culture, to differentiate into cell and tissue types derived from all three embryonic ge rm layers (endoderm, mesoderm and ectoderm). Methods for isolating a human embryonic stem cell line are also disclosed.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA2608833A1
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
title ESTABLISHMENT OF A HUMAN EMBRYONIC STEM CELL LINE USING MAMMALIAN CELLS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T04%3A57%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BIPASHA,%20BOSE&rft.date=2007-02-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2608833A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true